Vanguard Group’s PhaseRx, Inc. PZRX Stock Holding History

Vanguard Group’s Portfolio PZRX Stock Details PZRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-74,704	Closed	-$61K	–	4090
2017 Q3	$61K	Sell	74,704 -67,478	-47%	-$50.4K	﹤0.01%	4020
2017 Q2	$135K	Buy	142,182 +5,500	+4%	+$6.49K	﹤0.01%	3961
2017 Q1	$206K	Buy	136,682 +6,400	+5%	+$9.91K	﹤0.01%	3901
2016 Q4	$202K	Buy	+130,282	New	+$213K	﹤0.01%	3892

Other funds holding PZRX

RFC

Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Vanguard Group's PZRX Position: Q4 2017 in Review

Vanguard Group sold out of PhaseRx, Inc. (PZRX) in Q4 2017, closing a stake of 74,704 shares — an estimated $61K sold.

Vanguard Group first reported a position in PZRX in Q4 2016 and held it in 4 quarters. The position peaked at $206K in Q1 2017. 6 funds tracked by Wall St. Rank hold PZRX as of Q4 2017.

Vanguard Group reported no remaining PhaseRx, Inc. position as of Q4 2017 after selling out during the quarter.
Vanguard Group sold 74,704 PhaseRx, Inc. shares in Q4 2017, an estimated $61K.
Vanguard Group first reported a position in PhaseRx, Inc. in Q4 2016 and held it in 4 quarters.
Vanguard Group's PhaseRx, Inc. position peaked at $206K in Q1 2017.
6 funds tracked by Wall St. Rank held PhaseRx, Inc. as of Q4 2017.

Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.